Emerging methods for analysis of the cancer methylome

Jer Wei Chang, Tim Hui Ming Huang, Yi-Ching Wang

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

CpG island hypermethylation plays a key role in the silencing of cancer-related genes. In recent years, some new and effective methods have been developed for high-throughput analysis of DNA methylation, and have provided DNA methylation markers as powerful tools for the development of innovative diagnostic and therapeutic strategies in cancer. In this review, we describe various current and emerging technologies for studying the DNA methylation profile in cancer including: the isoschizomers and gel-based methylation analysis, the microarray-based methylation analysis and the sequencing-based methylation analysis. All of these techniques have advantages and disadvantages, such as sensitivity, specificity, analysis scale and cost. In the coming years, newer platforms of low cost, high-throughput and greater expediency, and speed for cancer methylome analysis will be developed.

Original languageEnglish
Pages (from-to)1869-1878
Number of pages10
JournalPharmacogenomics
Volume9
Issue number12
DOIs
Publication statusPublished - 2008 Dec 1

Fingerprint

DNA Methylation
Methylation
Costs and Cost Analysis
Neoplasms
CpG Islands
Neoplasm Genes
Microarray Analysis
Genetic Markers
Gels
Technology
Sensitivity and Specificity
Therapeutics

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Genetics
  • Pharmacology

Cite this

Chang, Jer Wei ; Huang, Tim Hui Ming ; Wang, Yi-Ching. / Emerging methods for analysis of the cancer methylome. In: Pharmacogenomics. 2008 ; Vol. 9, No. 12. pp. 1869-1878.
@article{60b1648636294833947fc4c88d18e6d7,
title = "Emerging methods for analysis of the cancer methylome",
abstract = "CpG island hypermethylation plays a key role in the silencing of cancer-related genes. In recent years, some new and effective methods have been developed for high-throughput analysis of DNA methylation, and have provided DNA methylation markers as powerful tools for the development of innovative diagnostic and therapeutic strategies in cancer. In this review, we describe various current and emerging technologies for studying the DNA methylation profile in cancer including: the isoschizomers and gel-based methylation analysis, the microarray-based methylation analysis and the sequencing-based methylation analysis. All of these techniques have advantages and disadvantages, such as sensitivity, specificity, analysis scale and cost. In the coming years, newer platforms of low cost, high-throughput and greater expediency, and speed for cancer methylome analysis will be developed.",
author = "Chang, {Jer Wei} and Huang, {Tim Hui Ming} and Yi-Ching Wang",
year = "2008",
month = "12",
day = "1",
doi = "10.2217/14622416.9.12.1869",
language = "English",
volume = "9",
pages = "1869--1878",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "12",

}

Emerging methods for analysis of the cancer methylome. / Chang, Jer Wei; Huang, Tim Hui Ming; Wang, Yi-Ching.

In: Pharmacogenomics, Vol. 9, No. 12, 01.12.2008, p. 1869-1878.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Emerging methods for analysis of the cancer methylome

AU - Chang, Jer Wei

AU - Huang, Tim Hui Ming

AU - Wang, Yi-Ching

PY - 2008/12/1

Y1 - 2008/12/1

N2 - CpG island hypermethylation plays a key role in the silencing of cancer-related genes. In recent years, some new and effective methods have been developed for high-throughput analysis of DNA methylation, and have provided DNA methylation markers as powerful tools for the development of innovative diagnostic and therapeutic strategies in cancer. In this review, we describe various current and emerging technologies for studying the DNA methylation profile in cancer including: the isoschizomers and gel-based methylation analysis, the microarray-based methylation analysis and the sequencing-based methylation analysis. All of these techniques have advantages and disadvantages, such as sensitivity, specificity, analysis scale and cost. In the coming years, newer platforms of low cost, high-throughput and greater expediency, and speed for cancer methylome analysis will be developed.

AB - CpG island hypermethylation plays a key role in the silencing of cancer-related genes. In recent years, some new and effective methods have been developed for high-throughput analysis of DNA methylation, and have provided DNA methylation markers as powerful tools for the development of innovative diagnostic and therapeutic strategies in cancer. In this review, we describe various current and emerging technologies for studying the DNA methylation profile in cancer including: the isoschizomers and gel-based methylation analysis, the microarray-based methylation analysis and the sequencing-based methylation analysis. All of these techniques have advantages and disadvantages, such as sensitivity, specificity, analysis scale and cost. In the coming years, newer platforms of low cost, high-throughput and greater expediency, and speed for cancer methylome analysis will be developed.

UR - http://www.scopus.com/inward/record.url?scp=61549137178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61549137178&partnerID=8YFLogxK

U2 - 10.2217/14622416.9.12.1869

DO - 10.2217/14622416.9.12.1869

M3 - Review article

C2 - 19072645

AN - SCOPUS:61549137178

VL - 9

SP - 1869

EP - 1878

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 12

ER -